Summit Trail Advisors LLC acquired a new stake in Concentrix Corporation (NASDAQ:CNXC - Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 9,038 shares of the company's stock, valued at approximately $503,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Steward Partners Investment Advisory LLC grew its holdings in Concentrix by 81.3% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 638 shares of the company's stock worth $28,000 after purchasing an additional 286 shares during the period. UMB Bank n.a. raised its holdings in shares of Concentrix by 47.3% during the first quarter. UMB Bank n.a. now owns 676 shares of the company's stock valued at $38,000 after purchasing an additional 217 shares during the period. Fifth Third Bancorp boosted its position in shares of Concentrix by 36.5% during the 1st quarter. Fifth Third Bancorp now owns 2,051 shares of the company's stock worth $114,000 after purchasing an additional 548 shares in the last quarter. Versant Capital Management Inc grew its stake in shares of Concentrix by 582.5% in the 1st quarter. Versant Capital Management Inc now owns 2,109 shares of the company's stock valued at $117,000 after buying an additional 1,800 shares during the period. Finally, GAMMA Investing LLC increased its position in Concentrix by 761.3% in the 1st quarter. GAMMA Investing LLC now owns 2,446 shares of the company's stock valued at $136,000 after buying an additional 2,162 shares in the last quarter. Institutional investors own 90.34% of the company's stock.
Insider Activity at Concentrix
In related news, CEO Christopher A. Caldwell purchased 1,000 shares of the firm's stock in a transaction dated Monday, April 21st. The stock was bought at an average price of $46.00 per share, for a total transaction of $46,000.00. Following the purchase, the chief executive officer directly owned 303,362 shares in the company, valued at approximately $13,954,652. This trade represents a 0.33% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Cormac J. Twomey sold 500 shares of Concentrix stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $57.06, for a total transaction of $28,530.00. Following the completion of the sale, the executive vice president directly owned 38,130 shares in the company, valued at $2,175,697.80. This trade represents a 1.29% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 30,444 shares of company stock worth $1,482,503. 3.20% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
A number of research firms recently weighed in on CNXC. Robert W. Baird upped their price target on Concentrix from $62.00 to $72.00 and gave the stock an "outperform" rating in a research note on Thursday, June 26th. Wall Street Zen downgraded shares of Concentrix from a "buy" rating to a "hold" rating in a report on Saturday, June 21st. Bank of America dropped their price objective on shares of Concentrix from $65.00 to $61.00 and set a "neutral" rating on the stock in a research note on Friday, June 27th. Canaccord Genuity Group reaffirmed a "buy" rating and set a $80.00 target price on shares of Concentrix in a research report on Monday. Finally, Barrington Research reissued an "outperform" rating and issued a $54.00 price target on shares of Concentrix in a research report on Tuesday, June 24th. Two research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $66.75.
Check Out Our Latest Stock Analysis on CNXC
Concentrix Stock Performance
Shares of Concentrix stock traded down $0.28 during mid-day trading on Friday, hitting $56.50. 598,176 shares of the stock were exchanged, compared to its average volume of 738,634. Concentrix Corporation has a 12 month low of $36.28 and a 12 month high of $77.00. The company has a 50-day simple moving average of $54.56 and a 200 day simple moving average of $49.90. The company has a market capitalization of $3.61 billion, a P/E ratio of 15.52, a P/E/G ratio of 0.75 and a beta of 0.53. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.65 and a current ratio of 1.61.
Concentrix (NASDAQ:CNXC - Get Free Report) last issued its quarterly earnings results on Thursday, June 26th. The company reported $2.70 EPS for the quarter, missing analysts' consensus estimates of $2.76 by ($0.06). Concentrix had a net margin of 2.54% and a return on equity of 16.31%. The business had revenue of $2.42 billion for the quarter, compared to analysts' expectations of $2.38 billion. During the same period in the previous year, the business posted $2.69 earnings per share. The business's revenue was up 1.5% compared to the same quarter last year. Sell-side analysts anticipate that Concentrix Corporation will post 10.11 earnings per share for the current fiscal year.
Concentrix Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, August 5th. Investors of record on Friday, July 25th will be issued a $0.3328 dividend. This represents a $1.33 dividend on an annualized basis and a dividend yield of 2.36%. The ex-dividend date is Friday, July 25th. Concentrix's dividend payout ratio (DPR) is currently 36.54%.
Concentrix Company Profile
(
Free Report)
Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.
Recommended Stories

Before you consider Concentrix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.
While Concentrix currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.